Glycemic Control Reverses Increases in Urinary Excretions of Immunoglobulin G and Ceruloplasmin in Type 2 Diabetic Patients with Normoalbuminuria

 

 Buy Article Permissions and Reprints

To examine whether urinary excretions of plasma proteins with molecular radii of 45 - 55 Å and different isoelectric points such as IgG (pl = 7.4) and ceruloplasmin (pl = 4.4) increase selectively in normoalbuminuric type 2 diabetic patients, urinary albumin excretion rate (AER), renal clearances of IgG, ceruloplasmin and α2-macroglobulin, and creatinine clearance (Ccr) were studied in timed overnight urine samples of 36 diabetic outpatients and 16 control subjects. Furthermore, to examine effect of glycemic control on these urinary protein excretions, the same analysis was performed before and after glycemic control in 17 diabetic inpatients admitted for glycemic control. Renal clearances of IgG and ceruloplasmin were significantly higher in diabetic outpatients than in the control group, whereas AER and renal clearance of α2-macroglobulin did not differ. Glycemic control caused significant decreases in renal clearances of IgG and ceruloplasmin, accompanied with tendency for Ccr to decrease (p = 0.055). The present results, together with our previous finding of selectively increased urinary excretions of 45 - 55 Å sized plasma proteins in parallel with enhanced glomerular filtration rate after acute protein loading, led us to conclude that enhanced intraglomerular hydraulic pressure may cause increases in clearances of IgG and ceruloplasmin, and that this change can be reversed by strict glycemic control in normoalbuminuric diabetic patients.

References

• 1 Parving H H, Osterby R, Anderson P, Whsueh W A. Diabetic nephropathy. In: Brenner BM (ed). The Kidney. 5th ed.  Philadelphia: ; Saunders, 1996: 1864-1892
  Google Scholar
• 2 Nakamura Y, Myers B D. Charge selectivity of proteinuria in diabetic glomerulopathy.  Diabetes. 1988;  37 1202-1211
  CrossrefPubMedGoogle Scholar
• 3 Pietravalle P, Morano S, Cristina G, De Rossi M G, Mariani G, Cotroneo P, Ghirlanda G, Clementi A, Andreani D, Di Mario U. Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance.  Diabetes. 1991;  40 1685-1690
  PubMedGoogle Scholar
• 4 Deckert T, Kofoed-Enevoldsen A, Vidal P, Nørgaard K, Andreasen H B, Feldt-Rasmussen B. Size- and charge-selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria.  Diabetologia. 1993;  36 244-251
  CrossrefPubMedGoogle Scholar
• 5 Morano S, Pietravalle P, De Rossi M G, Mariani G, Cristina G, Medici F, Sensi M, Andreani D, Di Mario U. A charge selectivity impairment in protein permselectivity is present in type 2 diabetes.  Acta Diabetol. 1993;  30 138-142
  CrossrefPubMedGoogle Scholar
• 6 Fox J G, Quinn J D, Paterson K R, O’Reilly D StJ, Smith M P, Boulton-Jones J M. Glomerular charge selectivity in type 1 (insulin-dependent) diabetes mellitus.  Diabet Med. 1995;  12 387-391
  PubMedGoogle Scholar
• 7 Torffvit O, Rippe B. Size and charge selectivity of glomerular filter in patients with insulin-dependent diabetes mellitus: Urinary immunoglobulins and glycosaminoglycans.  Nephron. 1999;  83 301-307
  CrossrefPubMedGoogle Scholar
• 8 Myers B D, Winetz J A, Chui F, Michaels A S. Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function.  Kidney Int. 1982;  21 633-641
  PubMedGoogle Scholar
• 9 Tomlanovich S, Been W M, Jones HW I II, Schwartz H C, Myers B D. Functional nature of the glomerular injury in progressive diabetic glomerulopathy.  Diabetes. 1987;  36 556-565
  PubMedGoogle Scholar
• 10 Scandling J D, Myers B D. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease.  Kidney Int. 1992;  41 840-846
  CrossrefPubMedGoogle Scholar
• 11 Gall M A, Rossing P, Kofoed-Enevoldsen A, Nielsen F S, Parving H H. Glomerular size- and charge-selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.  Diabetologia. 1994;  37 195-201
  CrossrefPubMedGoogle Scholar
• 12 Myers B D, Nelson R G, Williams G W, Bennett P H, Hardy S A, Berg R L, Loon N, Knowler W C, Mitch W E. Glomerular function in Pima Indians with non-insulin-dependent diabetes mellitus of recent onset.  J Clin Invest. 1991;  88 524-530
  PubMedGoogle Scholar
• 13 Hostetter T H, Rennke H G, Brenner B M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.  Am J Med. 1982;  72 375-380
  CrossrefPubMedGoogle Scholar
• 14 Zatz R, Meyer T W, Rennke H G, Brenner B M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.  Proc Natl Acad Sci USA. 1985;  82 5963-5967
  PubMedGoogle Scholar
• 15 Anderson S, Brenner B M. Pathogenesis of diabetic nephropathy: Hemodynamic considerations.  Diabetes Metab Rev. 1988;  4 163-177
  CrossrefPubMedGoogle Scholar
• 16 Tencer J, Torflfrit O, Thysell H, Rippe B, Grubb A. Proteinuria selectivity index based upon α2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases.  Kidney Int. 1998;  54 2098-2105
  CrossrefPubMedGoogle Scholar
• 17 Narita T, Koshimura J, Suzuki K, Murata M, Meguro H, Fujita H, Kitazato H, Ito S. Effects of short-term glycemic control, low protein diet and administration of enarapril on renal hemodynamics and protein permselectivity in Type 2 diabetic patients with microalbuminuria.  Tohoku J Exp Med. 1999;  189 117-133
  CrossrefPubMedGoogle Scholar
• 18 Anderson S, Vora J P. Current concepts of renal hemodynamics in diabetes.  J Diabetes Complications. 1995;  9 304-307
  CrossrefPubMedGoogle Scholar
• 19 Narita T, Kitazato H, Koshimura J, Suzuki K, Murata M, Ito S. Effects of protein meals on the urinary excretion of various plasma proteins in healthy subjects.  Nephron. 1999;  81 398-405
  CrossrefPubMedGoogle Scholar
• 20 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus.  Diabetes Care. 1997;  20 1183-1195
  PubMedGoogle Scholar
• 21 Bertolatus J A, Abuyousef M, Hunsicker L G. Glomerular sieving of high molecular weight proteins in proteinuric rats.  Kidney Int. 1987;  31 1257-1266
  PubMedGoogle Scholar
• 22 Yamazaki M, Ito S, Usami A, Tani N, Hanyu O, Nakagawa O, Nakamura H, Shibata A. Urinary excretion rate of ceruloplasmin in non-insulin dependent diabetic patients with different stage of nephropathy.  Eur J Endocrinol. 1995;  132 681-687
  CrossrefPubMedGoogle Scholar
• 23 Ito S, Usami A, Yamazaki M, Shibata A. A radioimmunometric assay for urinary α2-macroglobulin.  Tohoku J Exp Med. 1995;  176 137-147
  CrossrefPubMedGoogle Scholar
• 24 Brodows R G, Nichols D, Shaker G, Kubasik N P. Evaluation of a new radioimmunoassay for urinary albumin.  Diabetes Care. 1986;  9 189-193
  PubMedGoogle Scholar
• 25 Maroni B J, Steinman T I, Mitch W E. A method for estimating nitrogen intake of patients with chronic renal failure.  Kidney Int. 1985;  27 58-65
  CrossrefPubMedGoogle Scholar
• 26 Paul A A, Southgate D AT. McCance and Widdowson’s The Composition of Foods, 4th ed.  London:; HMSO Books, 1978: 7-8
• 27 Isaksson B. Urinary nitrogen output as a validity test in dietary surveys.  Am J Clin Nutr. 1980;  33 4-5
  PubMedGoogle Scholar
• 28 Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure.  Arch Intern Med. 1997;  157 2413-2446
  CrossrefPubMedGoogle Scholar
• 29 American Diabetes Association. Standards of medical care for patients with diabetes mellitus.  Diabetes Care. 1998;  21 S23-S31
  PubMedGoogle Scholar
• 30 European Diabetes Policy Group. A desktop guideline to Type 2 diabetes mellitus.  Diabet Med. 1999;  16 716-730
  CrossrefPubMedGoogle Scholar
• 31 Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T. 1999 WHO-International Society of Hypertension Guidelines for the management of hypertension. Guidelines Sub-Committee.  Clin Exp Hypertens. 1999;  21 1009-1060
  PubMedGoogle Scholar
• 32 Ramsay L E, Williams B, Johnston G D, MacGregor G A, Poston L, Potter J F, Poulter N R, Russel G. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.  J Hum Hypertens. 1999;  13 569-592
  CrossrefPubMedGoogle Scholar
• 33 Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus.  Kidney Int. 1988;  33 100-106
  PubMedGoogle Scholar
• 34 Jerums G, Alien T J, Cooper M E. Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes.  Diabetic Med. 1989;  6 772-779
  CrossrefPubMedGoogle Scholar
• 35 Hoogenberg K, Sluiter W J, Navis G, Van Haeften T W, Smit A J, Reitsma W D, Dullaart R PF. Exogenous norepinephrine induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus.  J Am Soc Nephrol. 1998;  9 643-654
  PubMedGoogle Scholar
• 36 Fujita H, Narita T, Ito S. Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance.  Diabetes Care. 1999;  22 823-826
  PubMedGoogle Scholar
• 37 Deen W M, Bridges C R, Brenner B M, Myers B D. Heteroporous model of glomerular size selectivity: Application to normal and nephrotic humans.  Am J Physiol. 1985;  249 (Renal Fluid Electrolyte Physiol 18) F374-F389
  PubMedGoogle Scholar
• 38 Myers B D. Pathophysiology of proteinuria in immune glomerular injury.  Am J Nephrol. 1990;  10 19-23
  PubMedGoogle Scholar
• 39 Tencer J, Frick I M, Oqvist B, Aim P, Rippe B. Size selectivity of the glomerular barrier to high molecular weight proteins. The upper size limitation of the shunt pathways.  Kidney Int. 1998;  53 709-715
  CrossrefPubMedGoogle Scholar
• 40 Kaysen G A, Myers B D, Couser W G, Rabkin R, Felts J M. Biology of disease. Mechanisms and consequences of proteinuria.  Lab Invest. 1986;  54 479-498
  PubMedGoogle Scholar
• 41 Ishibashi F. Glomerular clearance and tubular reabsorption of IgGl and IgG4 in microalbuminuric patients with non-insulin-dependent diabetes mellitus (NIDDM).  Diabetes Res Clin Prac. 1993;  22 45-51
  CrossrefPubMedGoogle Scholar
• 42 Morelli E, Loon N, Meyer T W, Peters W, Myers B D. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.  Diabetes. 1990;  39 76-82
  PubMedGoogle Scholar
• 43 Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G C, Remuzzi G. Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy.  J Nephrol. 1993;  6 36-43
  PubMedGoogle Scholar
• 44 Rosenberg M E, Swanson J E, Thomas B L, Hostetter T H. Glomerular and hormonal response to dietary protein intake in human renal disease.  Am J Physiol. 1987;  253 (Renal Fluid Electrolyte Physiol 22) F1083-F1090
  PubMedGoogle Scholar

T. Narita,M.D. 

Division of Geriatric Medicine
Akita University Hospital

1-1-1 Hondo, Akita 010-8543
Japan


Phone: Phone:+ 81 (18) 884-6040

Fax: Fax:+ 81 (18) 884-6449

Email: E-mail:narita@med.akita-u.ac.jp